Jessica Young

4.9k total citations
29 papers, 652 citations indexed

About

Jessica Young is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jessica Young has authored 29 papers receiving a total of 652 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cancer Research, 13 papers in Oncology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jessica Young's work include Breast Cancer Treatment Studies (5 papers), Cancer Genomics and Diagnostics (5 papers) and MicroRNA in disease regulation (4 papers). Jessica Young is often cited by papers focused on Breast Cancer Treatment Studies (5 papers), Cancer Genomics and Diagnostics (5 papers) and MicroRNA in disease regulation (4 papers). Jessica Young collaborates with scholars based in United States, Japan and Jamaica. Jessica Young's co-authors include Kazuaki Takabe, Tsutomu Kawaguchi, Qianya Qi, Li Yan, Xuan Peng, Eigo Otsuji, Song Liu, Mateusz Opyrchal, Kerry-Ann McDonald and Santosh K. Patnaik and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and British Journal of Cancer.

In The Last Decade

Jessica Young

26 papers receiving 644 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jessica Young United States 12 331 270 243 159 106 29 652
Oriol Arpí Spain 15 149 0.5× 376 1.4× 359 1.5× 126 0.8× 64 0.6× 24 710
Evangelos Bournakis Greece 15 153 0.5× 267 1.0× 272 1.1× 160 1.0× 45 0.4× 35 621
Giuseppe Gullo Ireland 13 154 0.5× 368 1.4× 271 1.1× 151 0.9× 88 0.8× 42 692
Akshara Singareeka Raghavendra United States 16 259 0.8× 519 1.9× 263 1.1× 320 2.0× 92 0.9× 69 857
F. De Vita Italy 11 220 0.7× 405 1.5× 198 0.8× 196 1.2× 85 0.8× 37 691
Shuiping Gao China 13 194 0.6× 229 0.8× 263 1.1× 99 0.6× 74 0.7× 28 539
Kathryn Effendi Japan 16 198 0.6× 232 0.9× 359 1.5× 110 0.7× 55 0.5× 23 766
Tomohiro Miyake Japan 15 395 1.2× 268 1.0× 313 1.3× 112 0.7× 67 0.6× 55 749
Dan Lu China 9 131 0.4× 203 0.8× 458 1.9× 85 0.5× 94 0.9× 16 694
Sheng Ye China 15 182 0.5× 208 0.8× 283 1.2× 131 0.8× 97 0.9× 36 585

Countries citing papers authored by Jessica Young

Since Specialization
Citations

This map shows the geographic impact of Jessica Young's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jessica Young with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jessica Young more than expected).

Fields of papers citing papers by Jessica Young

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jessica Young. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jessica Young. The network helps show where Jessica Young may publish in the future.

Co-authorship network of co-authors of Jessica Young

This figure shows the co-authorship network connecting the top 25 collaborators of Jessica Young. A scholar is included among the top collaborators of Jessica Young based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jessica Young. Jessica Young is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Young, Jessica, Mariko Asaoka, Farhad Ghasemi, et al.. (2025). The American Joint Committee on Cancer (AJCC) Breast Cancer Staging, Eighth Edition, is more Reflective of Cancer Biology than the Seventh Edition. Annals of Surgical Oncology. 32(5). 3268–3277.
2.
Oshi, Masanori, Tsutomu Kawaguchi, Li Yan, et al.. (2021). Immune cytolytic activity is associated with reduced intra-tumoral genetic heterogeneity and with better clinical outcomes in triple negative breast cancer.. PubMed. 11(7). 3628–3644. 20 indexed citations
3.
Young, Jessica, et al.. (2021). Management of Male Breast Cancer: The Journey so Far and Future Directions. World Journal of Oncology. 12(6). 206–213. 8 indexed citations
4.
Tokumaru, Yoshihisa, et al.. (2021). Breast Cancer in Jamaica: Stage, Grade and Molecular Subtype Distributions Across Age Blocks, the Implications for Screening and Treatment. World Journal of Oncology. 12(4). 93–103. 8 indexed citations
5.
McDonald, Kerry-Ann, Tsutomu Kawaguchi, Qianya Qi, et al.. (2019). Tumor Heterogeneity Correlates with Less Immune Response and Worse Survival in Breast Cancer Patients. Annals of Surgical Oncology. 26(7). 2191–2199. 129 indexed citations
6.
Levine, Ellis, Kilian Salerno, Fan Zhang, et al.. (2018). Efficacy of Palbociclib Combinations in Hormone Receptor–Positive Metastatic Breast Cancer Patients After Prior Everolimus Treatment. Clinical Breast Cancer. 18(6). e1401–e1405. 21 indexed citations
7.
Yan, Li‐Xu, Qianya Qi, Xuan Peng, et al.. (2018). Novel MicroRNA-Based Risk Score Identified by Integrated Analyses to Predict Metastasis and Poor Prognosis in Breast Cancer. Annals of Surgical Oncology. 25(13). 4037–4046. 33 indexed citations
8.
Ramanathan, Rajesh, Ali Raza, Jamie Sturgill, et al.. (2017). Paradoxical Association of Postoperative Plasma Sphingosine-1-Phosphate with Breast Cancer Aggressiveness and Chemotherapy. Mediators of Inflammation. 2017. 1–7. 5 indexed citations
9.
Young, Jessica, Tsutomu Kawaguchi, Li Yan, et al.. (2017). Tamoxifen sensitivity-related microRNA-342 is a useful biomarker for breast cancer survival. Oncotarget. 8(59). 99978–99989. 44 indexed citations
10.
Kawaguchi, Tsutomu, Barbara A. Foster, Jessica Young, & Kazuaki Takabe. (2017). Current Update of Patient-Derived Xenograft Model for Translational Breast Cancer Research. Journal of Mammary Gland Biology and Neoplasia. 22(2). 131–139. 25 indexed citations
11.
Kim, Sara Y., Tsutomu Kawaguchi, Li Yan, et al.. (2017). Clinical Relevance of microRNA Expressions in Breast Cancer Validated Using the Cancer Genome Atlas (TCGA). Annals of Surgical Oncology. 24(10). 2943–2949. 53 indexed citations
12.
Kennedy, Claire, Dervla M. Connaughton, Susan Murray, et al.. (2017). Home haemodialysis in Ireland. QJM. 111(4). 225–229. 4 indexed citations
13.
Kawaguchi, Tsutomu, Li Yan, Qianya Qi, et al.. (2017). Overexpression of suppressive microRNAs, miR-30a and miR-200c are associated with improved survival of breast cancer patients. Scientific Reports. 7(1). 15945–15945. 64 indexed citations
14.
Sood, Ashwani, Joseph Geradts, & Jessica Young. (2017). Prostate-derived Ets factor, an oncogenic driver in breast cancer. Tumor Biology. 39(5). 3726130768–3726130768. 8 indexed citations
15.
Brady, William E., Thaer Khoury, Tracey L. O’Connor, et al.. (2016). Outcomes of neoadjuvant dual HER2 targeted therapy in HER2 amplified breast cancer in clinical practice: a single institutional experience.. Journal of Clinical Oncology. 34(15_suppl). e12096–e12096.
16.
Gabriel, Emmanuel, et al.. (2015). Impact of American College of Surgeons Oncology Group Z11 on surgical training at an academic cancer center. Journal of Surgical Research. 201(2). 266–271. 10 indexed citations
17.
McGuire, Kandace P., Jessica Young, Atilla Soran, et al.. (2011). MRI Staging After Neoadjuvant Chemotherapy for Breast Cancer: Does Tumor Biology Affect Accuracy?. Annals of Surgical Oncology. 18(11). 3149–3154. 94 indexed citations
18.
Walsh, Michael D., Margaret C. Cummings, Daniel D. Buchanan, et al.. (2010). Lynch syndrome-associated breast cancers: clinicopathological characteristics of a case series from the colon CFR. Journal of Gastroenterology and Hepatology. 25. 1 indexed citations
19.
Loddo, Marco, Sarah R. Kingsbury, Ian Proctor, et al.. (2009). Cell-cycle-phase progression analysis identifies unique phenotypes of major prognostic and predictive significance in breast cancer. British Journal of Cancer. 100(6). 959–970. 76 indexed citations
20.
Thame, M, et al.. (2004). An unusual presentation of group B streptococcal sepsis.. PubMed. 53(6). 416–9. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Oriol Arpí Breakdown of academic impact, for papers by Evangelos Bournakis Breakdown of academic impact, for papers by Giuseppe Gullo Breakdown of academic impact, for papers by Akshara Singareeka Raghavendra Breakdown of academic impact, for papers by F. De Vita Breakdown of academic impact, for papers by Shuiping Gao Breakdown of academic impact, for papers by Kathryn Effendi Breakdown of academic impact, for papers by Tomohiro Miyake Breakdown of academic impact, for papers by Dan Lu Breakdown of academic impact, for papers by Sheng Ye
Rankless by CCL
2026